China now drives first-in-class innovation, not just generics—and every Western pharma BD team underpricing that shift is building a...

Sanofi opened 2026 with momentum: first-quarter sales reached €10.5 billion, up 13.6% at constant exchange rates, and business EPS...

Ipsen posted first‑quarter 2026 sales of €1.07 billion, up 17% as reported and 22.6% at constant exchange rates, and...

Exicure has entered a co-development agreement with Korea-based ADBiotech to advance burixafor (GPC-100) in combination strategies across sickle cell...

TG Therapeutics used the AAN 2026 stage to advance the positioning of BRIUMVI in relapsing multiple sclerosis, presenting new...

Capricor Therapeutics presented Phase 3 HOPE-3 data for Deramiocel (CAP-1002) in Duchenne muscular dystrophy at the American Academy of...

FDA has approved Dupixent (dupilumab) for children aged two to 11 with chronic spontaneous urticaria (CSU) who remain symptomatic...

Elkedonia has appointed Pierre d’Epenoux as independent chairman as the Franco‑Belgian biotech advances a first‑in‑class program targeting ELK1 inhibition...

Humacyte’s bid to globalize its bioengineered vascular graft moved a step forward as Israel’s Ministry of Health accepted the...

Telix Pharmaceuticals will deliver late-breaking Part 1 data from its global Phase 3 ProstACT study of TLX591-Tx, a PSMA-targeted...